13F filer · CIK 1807489
M28 Capital Management LP
STAMFORD, CT · filing since Q4 2021 · last filing Aug 13, 2026
Reported value
$47.2M
$-6.6M vs prior
Positions
9
New / sold out
0 / 0
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $0
Top-10 weight
100.0%
Biggest buys vs Q1 2026
No new or increased positions this quarter.
Biggest sells vs Q1 2026
No reduced or sold positions this quarter.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | WAVE LIFE SCIENCES LTDSHS | 4,588,284 | $26.7M | 56.53% |
| 2 | INVIVYD INCCOM | 9,248,250 | $8.1M | 17.11% |
| 3 | TG THERAPEUTICS INCCOM | 88,354 | $4.9M | 10.29% |
| 4 | ARROWHEAD PHARMACEUTICALS INCOM | 36,851 | $3.0M | 6.37% |
| 5 | FRACTYL HEALTH INCCOM | 1,856,117 | $1.5M | 3.13% |
| 6 | PROQR THRAPEUTICS N VSHS EURO | 599,793 | $1.1M | 2.37% |
| 7 | SILENCE THERAPEUTICS PLCADS | 101,203 | $1.1M | 2.36% |
| 8 | ROCKET PHARMACEUTICALS INCCOM | 210,871 | $721.2K | 1.53% |
| 9 | CURIS INCCOM | 284,889 | $148.7K | 0.32% |